These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 1688885

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Measurement of antibody to Jo-1 by ELISA and comparison to enzyme inhibitory activity.
    Targoff IN, Reichlin M.
    J Immunol; 1987 May 01; 138(9):2874-82. PubMed ID: 3553328
    [Abstract] [Full Text] [Related]

  • 4. Patients with non-Jo-1 anti-RNA-synthetase autoantibodies have worse survival than Jo-1 positive patients.
    Hervier B, Devilliers H, Benveniste O.
    Ann Rheum Dis; 2013 Jul 01; 72(7):e18. PubMed ID: 23644669
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy.
    Stone KB, Oddis CV, Fertig N, Katsumata Y, Lucas M, Vogt M, Domsic R, Ascherman DP.
    Arthritis Rheum; 2007 Sep 01; 56(9):3125-31. PubMed ID: 17763431
    [Abstract] [Full Text] [Related]

  • 8. Frequent occurrence of anti-tRNA(His) autoantibodies that recognize a conformational epitope in sera of patients with myositis.
    Brouwer R, Vree Egberts W, Jongen PH, van Engelen BG, van Venrooij WJ.
    Arthritis Rheum; 1998 Aug 01; 41(8):1428-37. PubMed ID: 9704641
    [Abstract] [Full Text] [Related]

  • 9. HLA-D region genes associated with autoantibody responses to histidyl-transfer RNA synthetase (Jo-1) and other translation-related factors in myositis.
    Goldstein R, Duvic M, Targoff IN, Reichlin M, McMenemy AM, Reveille JD, Warner NB, Pollack MS, Arnett FC.
    Arthritis Rheum; 1990 Aug 01; 33(8):1240-8. PubMed ID: 1975177
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of antisynthetase-associated interstitial lung disease with tacrolimus.
    Wilkes MR, Sereika SM, Fertig N, Lucas MR, Oddis CV.
    Arthritis Rheum; 2005 Aug 01; 52(8):2439-46. PubMed ID: 16052580
    [Abstract] [Full Text] [Related]

  • 12. Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies.
    Dugar M, Cox S, Limaye V, Blumbergs P, Roberts-Thomson PJ.
    Intern Med J; 2011 Sep 01; 41(9):674-9. PubMed ID: 20059602
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance.
    Mimori T, Imura Y, Nakashima R, Yoshifuji H.
    Curr Opin Rheumatol; 2007 Nov 01; 19(6):523-9. PubMed ID: 17917530
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.